Is Lexapro Safe in Pregnancy? What the Guidance Actually Says

If you take escitalopram, sold under the brand name Lexapro, and you are pregnant or planning to be, you may feel caught between two worries: the medicine and the condition it treats. That is a common and understandable place to be. This article gathers what leading U.S. sources say about escitalopram in pregnancy so you can have a clearer conversation with the clinicians who manage your care. It is general education only and is not a substitute for that conversation.

What escitalopram is and what it treats

Escitalopram is a selective serotonin reuptake inhibitor, or SSRI. This medicine family also includes sertraline, fluoxetine, citalopram, and paroxetine. SSRIs are used to treat depression and several anxiety-related conditions. They work by increasing the availability of serotonin, a chemical messenger in the brain involved in mood. For many people these conditions are ongoing and need steady treatment, which is exactly why decisions about continuing during pregnancy deserve careful, individualized thought rather than a quick yes or no.

What the guidance says about pregnancy

The reassuring headline is that SSRIs, including escitalopram, are among the most studied medicines used in pregnancy. MotherToBaby, a service of the non-profit Organization of Teratology Information Specialists, reports that most studies have not found that escitalopram or its close relative citalopram increases the overall chance of birth defects. A few studies raised questions about heart defects, but MotherToBaby notes these had methodological limitations and that the broader body of evidence is largely reassuring.

The American College of Obstetricians and Gynecologists (ACOG) has taken a clear public position that SSRIs are an important and generally safe option in pregnancy for people who need them, and that most SSRIs do not increase the risk of birth defects. ACOG stresses that these medicines can be part of an effective treatment plan before, during, and after pregnancy.

Specific concerns that have been studied

Being reassured overall does not mean there is nothing to discuss. MotherToBaby describes several areas that researchers have looked at.

Miscarriage. Studies have not found a clear increase in the chance of miscarriage with these medicines.

Persistent pulmonary hypertension of the newborn (PPHN). Some studies have suggested that SSRI use in the second half of pregnancy might slightly raise the chance of PPHN, a serious lung condition. MotherToBaby describes the results as mixed and the absolute chance as small, on the order of well under one percent, against a background rate in the general population of roughly one to two per thousand births.

Newborn adjustment symptoms. Some babies exposed to SSRIs late in pregnancy show temporary symptoms after birth, such as jitteriness, irritability, tremors, constant crying, or changes in sleep and feeding. MotherToBaby notes these are usually mild and tend to resolve within days to a couple of weeks, generally without specific treatment.

Preterm birth. Some research suggests a possible small increase in the chance of preterm delivery, though depression itself is also associated with that risk, which makes the two hard to separate.

Child development. Studies on later ADHD or autism spectrum disorder have had mixed results, but most do not find an increased chance once family history and other factors are taken into account.

The other side: untreated depression carries risks too

It is easy to focus only on the medicine, but the condition matters just as much. ACOG points out that untreated or undertreated depression in pregnancy is not risk-free: it can be associated with poor engagement in prenatal care, inadequate nutrition and self-care, substance use, preterm birth, low birth weight, difficulty bonding with the baby, and, in serious cases, thoughts of self-harm. The goal your care team will aim for is effective, appropriate treatment, not simply stopping medication. For some people the safest plan is to continue; for others a change may make sense. That balance is personal.

Do not start or stop on your own

This is the most important practical point. Do not stop escitalopram abruptly on your own. SSRIs can cause discontinuation symptoms when stopped suddenly, such as dizziness, flu-like feelings, sleep disturbance, and mood changes, and stopping can also allow the underlying depression or anxiety to return, sometimes forcefully. If you are worried, the right move is to contact your prescriber and your OB and plan any change together. Likewise, do not start or switch an antidepressant during pregnancy without that same guidance. The decision is individualized and depends on your history, how well the medicine has worked, and how you are doing now.

A note on the old letter categories

You may have seen older references to FDA pregnancy “categories” such as A, B, C, D, and X. That system has been retired. U.S. drug labels now use a narrative format under the Pregnancy and Lactation Labeling Rule, which describes what is actually known rather than assigning a single letter. If you come across an old letter grade for escitalopram, treat it as out of date and ask your clinician for the current picture.

Breastfeeding

MotherToBaby reports that escitalopram and citalopram pass into breast milk in small amounts, and that most studies have not reported harmful effects on nursing babies, with only a few case reports. Many clinicians support breastfeeding while taking these medicines, but the right answer for a premature or medically fragile infant should be confirmed with your baby’s clinician.

When to call your OB or a specialist

Reach out to your obstetric provider and mental-health prescriber if you are pregnant or planning pregnancy and take escitalopram, if you are thinking about stopping or changing it, or if your mood or anxiety worsens. If your situation is complex, your team may involve a maternal-fetal-medicine specialist or a perinatal psychiatrist. For questions about a specific exposure, you can call MotherToBaby at 1-866-626-6847, a free service that answers questions about medicines in pregnancy and breastfeeding. If you ever have thoughts of harming yourself, call or text 988 right away.

Frequently asked questions

Is escitalopram safe to take while pregnant? For many people it can be an appropriate choice, but “safe” is individual. MotherToBaby and ACOG describe SSRIs as generally reassuring and most not linked to birth defects, while noting a few studied concerns. Decide with your OB and prescriber.

I took escitalopram before I knew I was pregnant. Should I worry? Try not to panic. Most research has not linked early SSRI use to an overall rise in birth defects. Tell your OB what you took and when, and ask questions there or through MotherToBaby.

Will my baby have withdrawal after birth? Some babies show temporary adjustment symptoms such as jitteriness or irritability. MotherToBaby reports these are usually mild and resolve within days to weeks. Your care team can watch for them.

Should I switch to a “safer” SSRI for pregnancy? Not on your own. The best medicine is often the one that has worked well for you. Any switch should be planned with your prescriber, because changing can risk relapse.

Can I breastfeed while taking it? MotherToBaby reports only small amounts reach breast milk and harmful effects are not expected in most cases. Confirm with your baby’s clinician, especially for a newborn or fragile infant.

What if I feel fine and want to stop? Talk to your prescriber first. Stopping abruptly can cause discontinuation symptoms and relapse, and many people benefit from staying on treatment through the higher-risk postpartum period.

Sources

• MotherToBaby (Organization of Teratology Information Specialists) — Citalopram | Escitalopram (Celexa | Lexapro) fact sheet.
• American College of Obstetricians and Gynecologists (ACOG) — guidance on treatment and management of mental health conditions during pregnancy and postpartum, and its statement on access to SSRIs during pregnancy.